Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P41180: Variant p.Phe881Leu

Extracellular calcium-sensing receptor
Gene: CASR
Feedback?
Variant information Variant position: help 881 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Phenylalanine (F) to Leucine (L) at position 881 (F881L, p.Phe881Leu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and aromatic (F) to medium size and hydrophobic (L) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help Found in a patient with hypercalciuric hypercalcemia; likely pathogenic; mutant CASR has a right-shifted dose-response to extracellular calcium concentrations; activated by a higher calcium concentrations than the wild-type. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 881 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1078 The length of the canonical sequence.
Location on the sequence: help LFKPSRNTIEEVRCSTAAHA F KVAARATLRRSNVSRKRSSS The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         LFKPSRNTIEEVRCSTAAHAFKVAARATLRRSNVSRKRSSS

Mouse                         LFKPSRNTIEEVRSSTAAHAFKVAARATLRRPNISRKRSSS

Rat                           LFKPSRNTIEEVRSSTAAHAFKVAARATLRRPNISRKRSSS

Pig                           LFKPSRNTIEEVRCSTAAHAFKVAARATLRRSNVSRQRSSS

Bovine                        LFKPSRNTIEEVRCSTAAHAFKVAARATLRRSNVSRQRSSS

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 20 – 1078 Extracellular calcium-sensing receptor
Topological domain 863 – 1078 Cytoplasmic
Region 880 – 900 Interaction with RNF19A
Helix 880 – 885



Literature citations
Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor.
Carling T.; Szabo E.; Bai M.; Ridefelt P.; Westin G.; Gustavsson P.; Trivedi S.; Hellman P.; Brown E.M.; Dahl N.; Rastad J.;
J. Clin. Endocrinol. Metab. 85:2042-2047(2000)
Cited for: VARIANT HYPERCALCIURIC HYPERCALCEMIA LEU-881; CHARACTERIZATION OF VARIANT HYPERCALCIURIC HYPERCALCEMIA LEU-881;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.